Gilead Sciences Newsroom

Gilead Sciences Price Target Maintained With a $80.00/Share by Cantor Fitzgerald

Dow Jones00:47

Leerink Partners Initiates Gilead Sciences(GILD.US) With Buy Rating, Announces Target Price $99

Futu News00:32

RBC Capital Reiterates Sector Perform on Gilead Sciences, Maintains $84 Price Target

BenzingaDec 11 23:43

Gilead Sciences Analyst Ratings

BenzingaDec 11 23:42

Jefferies Maintains Gilead Sciences(GILD.US) With Buy Rating, Raises Target Price to $115

Futu NewsDec 11 21:31

Gilead Sciences (GILD) Receives a Buy From Jefferies

TipRanksDec 11 21:09

A Quick Look at Today's Ratings for Gilead Sciences(GILD.US), With a Forecast Between $105 to $125

Futu NewsDec 11 21:00

Gilead Sciences' Strategic Focus on Lenacapavir and Lifecycle Management Drives Buy Rating

TipRanksDec 11 19:08

Oppenheimer raised the Target Price of Gilead Sciences to $115.

Gelonghui FinanceDec 11 16:54

Citi Maintains Gilead Sciences(GILD.US) With Buy Rating

Futu NewsDec 10 20:33

B of A Securities Reinstates Buy on Gilead Sciences, Announces $109 Price Target

BenzingaDec 10 20:25

Citi Remains a Buy on Gilead Sciences (GILD)

TipRanksDec 10 19:51

Gilead Sciences Is Maintained at Outperform by Oppenheimer

Dow JonesDec 10 18:53

Gilead Sciences Analyst Ratings

BenzingaDec 10 18:44

Wells Fargo Maintains Gilead Sciences(GILD.US) With Buy Rating, Maintains Target Price $105

Futu NewsDec 10 18:37

Oppenheimer Maintains Gilead Sciences(GILD.US) With Buy Rating, Raises Target Price to $115

Futu NewsDec 10 12:31

Analysts Offer Insights on Healthcare Companies: Xenon (XENE), Legend Biotech (LEGN) and Gilead Sciences (GILD)

TipRanksDec 9 22:53

Bernstein Maintains Gilead Sciences(GILD.US) With Buy Rating, Maintains Target Price $105

Futu NewsDec 6 18:31

Gilead Sciences Receives 'Buy' Rating Amid Strong HIV Market Position and Promising Future Prospects

TipRanksDec 6 18:19

Piper Sandler Maintains Gilead Sciences(GILD.US) With Buy Rating, Maintains Target Price $105

Futu NewsDec 6 00:33